Viability test exclusively is not adequate to evaluate the T4 Acanthamoeba keratitis’ treatment

dc.creatorSilva, Geisa Bernardes da
dc.creatorAlves, Daniella de Sousa Mendes Moreira
dc.creatorAlves, Luciano Moreira
dc.creatorCastro, Ana Maria de
dc.creatorVinaud, Marina Clare
dc.date.accessioned2025-02-28T10:13:12Z
dc.date.available2025-02-28T10:13:12Z
dc.date.issued2020
dc.description.abstractAcanthamoeba keratitis is a serious corneal infection and can lead to blindness. Cysts and recurrence of infection represent a challenge in the treatment of keratitis due to its high resistance to adverse conditions and to most medications. This intriguing property can lead to late diagnosis and can explain absence of cyst removal during and after therapy regimen. So the evaluation of Acanthamoeba cysts viability after exposure to drugs used in Acanthamoeba keratitis treatment is so important. Material and methods: Cysts (105 /mL) of two clinical and an environmental T4 isolates were separately incubated with polyhexamethylene biguanide (0.02%), chlorhexidine digluconate (0.02%) or propamidine isethionate (0.1%) at 37 °C for a period of 1h or 24h. Cysts were quantified, stained with trypan blue and inoculated in agar plates covered with inactivated Escherichia coli. Results: None of the treatment regimens induced complete cysts elimination. The environmental isolate had no reduction on cysts quantification compared to clinical isolates. The trypan blue exclusion method demonstrated non-viable cysts in the treatment with chlorhexidine digluconate and propamidine isethionate. In the treatment with polyhemamethylene biguanide, viable and non-viable cysts were observed after 24h of incubation. The cultures were positive for all treatment protocols except for clinical isolate ATCC 30461 with chlorhexidine digluconate regimen after 24 h. Conclusions: The presence of cysts observed in cultures reiterates cysts viability even after treatment demonstrating the demonstrating the need to follow up this form of development during treatment. The trypan blue staining is not adequate to evaluate the Acanthamoeba cysts viability due to its recovery in culture. With these results, we conclude that the viability test exclusively is not adequate to evaluate the Acanthamoeba keratitis treatment and that its always necessary to perform culture technique.
dc.identifier.citationBERNARDES, Geisa et al. Viability test exclusively is not adequate to evaluate the T4 Acanthamoeba keratitis treatment. Journal of Microbiology & Experimentation, Budapeste, v. 8, n. 1, p. 1-5, 2020. DOI: 10.15406/jmen.2020.08.00278. Disponível em: https://medcraveonline.com/JMEN/viability-test-exclusively-is-not-adequate-to-evaluate-the-t4-acanthamoeba-keratitis-treatment.html. Acesso em: 20 fev. 2025.
dc.identifier.doi10.15406/jmen.2020.08.00278
dc.identifier.issne- 2373-437X
dc.identifier.urihttp://repositorio.bc.ufg.br//handle/ri/26778
dc.language.isoeng
dc.publisher.countryOutros
dc.publisher.departmentInstituto de Patologia Tropical e Saúde Pública - IPTSP (RMG)
dc.rightsAcesso Aberto
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectAcanthamoeba
dc.subjectViability
dc.subjectCulture
dc.subjectPolyhexamethylene biguanide
dc.subjectChlorhexidine digluconate
dc.subjectPropamidine isethionate
dc.subjectTrypan blue
dc.titleViability test exclusively is not adequate to evaluate the T4 Acanthamoeba keratitis’ treatment
dc.typeArtigo

Arquivos

Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
Artigo - Geisa Bernardes da Silva - 2020.pdf
Tamanho:
737.5 KB
Formato:
Adobe Portable Document Format
Licença do Pacote
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: